These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 22139692

  • 1. Preparation of lovastatin matrix sustained-release pellets by extrusion-spheronization combined with microcrystal dispersion technique.
    He H, Shi B, Cai C, Tang X.
    Arch Pharm Res; 2011 Nov; 34(11):1931-8. PubMed ID: 22139692
    [Abstract] [Full Text] [Related]

  • 2. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME.
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [Abstract] [Full Text] [Related]

  • 3. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M, Newton M, Booth S, Clarke A.
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [Abstract] [Full Text] [Related]

  • 4. Release behaviour of clozapine matrix pellets based on percolation theory.
    Aguilar-de-Leyva A, Sharkawi T, Bataille B, Baylac G, Caraballo I.
    Int J Pharm; 2011 Feb 14; 404(1-2):133-41. PubMed ID: 21094234
    [Abstract] [Full Text] [Related]

  • 5. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov 14; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 6. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
    Ige PP, Gattani SG.
    Arch Pharm Res; 2012 Mar 14; 35(3):487-98. PubMed ID: 22477196
    [Abstract] [Full Text] [Related]

  • 7. Approaches to developing fast release pellets via wet extrusion-spheronization.
    Xia Y, Shi CY, Fang JG, Wang WQ.
    Pharm Dev Technol; 2018 Jun 14; 23(5):432-441. PubMed ID: 27882815
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM, Sankalia MG, Mashru RC.
    J Control Release; 2008 Jul 02; 129(1):49-58. PubMed ID: 18456362
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N, Kleinebudde P, Puttipipatkhachorn S.
    J Pharm Sci; 2007 Sep 02; 96(9):2469-84. PubMed ID: 17286294
    [Abstract] [Full Text] [Related]

  • 16. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
    Yadav D, Survase S, Kumar N.
    Int J Pharm; 2011 Oct 31; 419(1-2):121-30. PubMed ID: 21807081
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y, Sun Y, Sun J, Zhao N, Sun M, He Z.
    Int J Pharm; 2012 Apr 15; 426(1-2):21-28. PubMed ID: 22266529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.